UK watchdog probes AstraZeneca’s $39bn Alexion acquisition
AstraZeneca recently received the US Federal Trade Commission (FTC) approval for the proposed acquisition of Alexion
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
26 May 21
AstraZeneca recently received the US Federal Trade Commission (FTC) approval for the proposed acquisition of Alexion
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
25 May 21
The coadministration trial is primarily aimed at determining the safety when both vaccines are co-administered, with follow up…
25 May 21
Zydus claims that Ujvira is the world’s first biosimilar antibody-drug conjugate of trastuzumab emtansine and will be offered…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
24 May 21
Equipped with advanced production lines, Samsung Biologics' facilities will support the production of hundreds of millions of doses…
24 May 21
The US FDA has also approved Guardant Health's Guardant360 CDx liquid biopsy blood test as a companion diagnostic…
21 May 21
The FDA approval expands the role of Opdivo in earlier stages of the disease, with two indications across…
21 May 21
GSK and Innoviva have jointly developed Trelegy Ellipta, Relvar Ellipta, and Anoro Ellipta drugs for use in asthma…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
20 May 21
The collaboration will deploy AI to advance the discovery of small molecule therapeutic drug candidates in multiple therapeutic…
20 May 21
The new cGMP facility will be designed to provide an end-to-end solution to advance cell therapy development and…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
18 May 21
The vaccine showed immune responses consistent with those measured in people recovered from Covid-19, in all adult age…